The Impact of the BRAF V600E Mutation on Recurrence and Survival in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis
The prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma (PTC) remains uncertain, partly because persistent disease and true recurrence have often been combined and overlapping cohorts and effect measures have been handled inconsistently. This systematic review and meta-analysis evaluated recurren...